Gsk (GSK) Non Operating Income (2009 - 2023)
Gsk (GSK) posted quarterly Non Operating Income of -$211.5 million for Q1 2023, up 19.99% year-over-year from -$176.3 million in Q1 2022, and up 19.99% quarter-over-quarter from -$264.3 million in Q1 2022.
Gsk (GSK) Non Operating Income (2009 - 2023) Analysis & Trends
Gsk's Non Operating Income history runs 12 years deep, the most recent figure standing at -$211.5 million for Q1 2023.
- In Q1 2023, Non Operating Income rose 19.99% year-over-year to -$211.5 million; the TTM figure through Mar 2023 stood at -$988.5 million (up 4.55% YoY), while the FY2020 annual figure was $83.5 million, up 226.86% from the prior year.
- Non Operating Income for Q1 2023 stood at -$211.5 million, up from -$264.3 million in the prior quarter.
- The five-year high for Non Operating Income was -$211.5 million in Q1 2023, with the low at -$264.3 million in Q1 2022.
- The 3-year median for Non Operating Income is -$260.3 million (2021), against an average of -$251.5 million.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income retreated 0.9% in 2022, then climbed 19.99% in 2023.
- Gsk's Non Operating Income stood at -$250.7 million in 2021, then retreated by 5.43% to -$264.3 million in 2022, then rose by 19.99% to -$211.5 million in 2023.
- Business Quant data shows GSK's Non Operating Income at -$211.5 million in Q1 2023, -$264.3 million in Q1 2022, and -$250.7 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -211.50 Mn |
| Mar 31, 2022 | -264.34 Mn |
| Dec 31, 2021 | -250.73 Mn |
| Sep 30, 2021 | -261.93 Mn |
| Jun 30, 2021 | -258.58 Mn |
| Mar 31, 2021 | -261.99 Mn |
| Dec 31, 2018 | -711.58 Mn |
| Dec 31, 2017 | 888.21 Mn |
| Dec 31, 2016 | -215.08 Mn |
| Dec 31, 2014 | 1.04 Bn |
| Dec 31, 2013 | 1.14 Bn |
| Dec 31, 2012 | 1.17 Bn |
| Dec 31, 2011 | 1.11 Bn |
| Dec 31, 2010 | 1.13 Bn |
| Dec 31, 2009 | 1.16 Bn |